Reports and Presentations
Note: These files are in PDF format unless otherwise noted.
November 5, 2020
Report evaluates the feasibility of requiring trauma service area regional advisory councils to implement a program to allow emergency medical services providers to navigate medically stable psychiatric emergency detention patients to the most appropriate setting.
November 2, 2020
The Report is the Annual Performance Report for the Prescription Drug Rebate Program (Attachment 1), as required by House Bill 1, 86th Legislature, Regular Session, 2019 (Article II, Health and Human Services Commission, Rider 119).
October 30, 2020
This report is the evaluation of Reimbursement Methodology and Payment Rates for Substance Use Treatment Services. This report presents findings from the evaluation of reimbursement methodology and payment rates for substance use treatment services provided under strategy D.2.4., which include substance use prevention, intervention, and treatment.
This report gives information on mental health waiting lists during the first two quarters of fiscal year 2020.
October 27, 2020
This report describes collaborative efforts undertaken by HHS, DSHS, ERS, TDCJ, TRS and the UT HealthScience Center at Houston to develop a data system to support cross-agency quality improvement and value-based healthcare activities, provides initial results and discusses next steps for the initiative.
October 6, 2020
Annual report on the actual expenditures from the previous fiscal year for all opioid abuse and misuse-related
programs within Texas Health and Human Services.
September 8, 2020
This progress report discusses potential untapped funding sources and other strategies for maximizing funding or cost savings in the Early Childhood Intervention (ECI) program.
September 2, 2020
The report evaluation existing pre-eligibility and post-eligibility processes and describes how the processes and associated data reviewed satisfy the intent behind the matches requested by the rider.
September 1, 2020
The Report is the Evaluation of Opioid Drug Prescribing Practices Under Medicaid (Attachment 1), as required by House Bill 1, 86th Legislature, Regular Session, 2019 (Article II, Health and Human Services Commission, Rider 34).
The report details the agency's strategic plan for vacant or underutilized FTE positions, explains agency FTE position management methodology and policy, and an overview of current and prospective agency actions, including the future disposition of reductions.